SAMHSA's updated regulations for opioid treatment programs revolutionize access to medication, expand telehealth options, and address workforce shortages, promising better outcomes for patients.
AI's potential to lower costs and alleviate physician burnout captivates hospitals and policymakers, yet challenges like accuracy and bias persist.
Ibogaine, derived from a shrub in Central Africa, shows promise in combating opioid addiction and crack cocaine dependency, with small studies reporting remarkable efficacy.
Efforts to address stigma, expand access to care, and promote community engagement are essential to breaking down barriers and fostering a more equitable and compassionate approach to SUD treatment.
Through the stories of Dr. Lisa Harbury Lerner and Dr. Lorna Breen, we explore the pain mental health stigma causes.
Could FDA restrictions be the latest move in combating the opioid crisis? Discover the future of painkiller medications.
Publicis Health paid a $350 million settlement for helping Purdue Pharma fuel the opioid epidemic with the marketing of OxyContin.
Haven Health Management explores the threat of opioids at the southern border.
By Chad Sabora Disparities in healthcare access have remained a persistent challenge in the United States. A core value in the quest for social justice, addressing these disparities is not just a goal for policymakers and healthcare professionals, it’s a call to action for all Americans. Equity in healthcare is not a luxury; it’s a […]
Vice President Kamala Harris announced that the Biden administration has invested $285 million to help schools hire and train more than 14,000 mental health counselors. The $285 million is funded by the Safer Communities Act, the bipartisan gun violence prevention legislation signed by President Biden in June 2022. The funding provided is considered to be […]